NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

Recruiting now · Phase 3

Conditions studied: Schizophrenia

In brief

This study will evaluate the long-term safety of NBI-1117568 in adults with schizophrenia.

Key facts

Study ID

NCT07114874

Run by

Neurocrine Biosciences

People needed

600

Starts

2025-07-11

Expected to finish

2031-12-01

Last updated by the study team

2026-06-05

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Neurocrine Clinical Site — Little Rock, Arkansas, United States (enrolling)
• Neurocrine Clinical Site — Cerritos, California, United States (enrolling)
• Neurocrine Clinical Site — Chino, California, United States (enrolling)
• Neurocrine Clinical Site — Culver City, California, United States (enrolling)
• Neurocrine Clinical Site — Garden Grove, California, United States (enrolling)
• Neurocrine Clinical Site — La Habra, California, United States (enrolling)
• Neurocrine Clinical Site — Lemon Grove, California, United States (enrolling)
• Neurocrine Clinical Site — Oceanside, California, United States (enrolling)
• Neurocrine Clinical Site — Pico Rivera, California, United States (enrolling)
• Neurocrine Clinical Site — Riverside, California, United States (enrolling)
• Neurocrine Clinical Site — San Diego, California, United States (enrolling)
• Neurocrine Clinical Site — Sherman, California, United States (enrolling)
• Neurocrine Clinical Site — Torrance, California, United States (enrolling)
• Neurocrine Clinical Site — West Hills, California, United States (enrolling)
• Neurocrine Clinical Site — Atlantis, Florida, United States (enrolling)
• Neurocrine Clinical Site — Aventura, Florida, United States (enrolling)
• Neurocrine Clinical Site — Doral, Florida, United States (enrolling)
• Neurocrine Clinical Site — Hollywood, Florida, United States (enrolling)
• Neurocrine Clinical Site — Maitland, Florida, United States (enrolling)
• Neurocrine Clinical Site — Miami, Florida, United States (enrolling)
• Neurocrine Clinical Site — Miami, Florida, United States (enrolling)
• Neurocrine Clinical Site — Miami Lakes, Florida, United States (enrolling)
• Neurocrine Clinical Site — Tampa, Florida, United States (enrolling)
• Neurocrine Clinical Site — West Palm Beach, Florida, United States (enrolling)
• Neurocrine Clinical Site — Bryant, Arkansas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.